|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goff BA, Mandel L, Muntz HG and Melancon
CH: Ovarian carcinoma diagnosis. Cancer. 89:2068–2075. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bast RC Jr, Hennessy B and Mills GB: The
biology of ovarian cancer: New opportunities for translation. Nat
Rev Cancer. 9:415–428. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bookman MA, Brady MF, McGuire WP, Harper
PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, De
Geest K, et al: Evaluation of new platinum-based treatment regimens
in advanced-stage ovarian cancer: A Phase III Trial of the
Gynecologic Cancer Intergroup. J Clin Oncol. 27:1419–1425. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schwarz R, Bruland O, Cassoni A, Schomberg
P and Bielack S: The role of radiotherapy in oseosarcoma. Cancer
Treat Res. 152:147–164. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang YC, Jiang G, Gao H, Liu HM and Liang
J: Influence of ionizing radiation on ovarian carcinoma SKOV-3
xenografts in nude mice under hypoxic conditions. Asian Pac J
Cancer Prev. 15:2353–2358. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Di Pasqua AJ, Yuan H, Chung Y, Kim JK,
Huckle JE, Li C, Sadgrove M, Tran TH, Jay M and Lu X:
Neutron-activatable holmium-containing mesoporous silica
nanoparticles as a potential radionuclide therapeutic agent for
ovarian cancer. J Nucl Med. 54:111–116. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wakeford R: The cancer epidemiology of
radiation. Oncogene. 23:6404–6428. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yu JH, Cui Q, Jiang YY, Yang W, Tashiro S,
Onodera S, Onodera S and Ikejima T: Pseudolaric acid B induces
apoptosis, senescence, and mitotic arrest in human breast cancer
MCF-7. Acta Pharmacol Sin. 28:1975–1983. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li E, Clark AM and Hufford CD: Antifungal
evaluation of pseudolaric acid B, a major constituent of
Pseudolarix kaempferi. J Nat Prod. 58:57–67. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang WC, Lu RF, Zhao SX and Gu ZP:
Comparison of early pregnancy-terminating effect and toxicity
between pseudolaric acids A and B. Zhongguo Yao Li Xue Bao.
9:445–448. 1988.(In Chinese). PubMed/NCBI
|
|
12
|
Wang WC, Lu RF, Zhao SX and Zhu YZ:
Antifertility effect of pseudolaric acid B. Zhongguo Yao Li Xue
Bao. 3:188–192. 1982.(In Chinese). PubMed/NCBI
|
|
13
|
Yu B, Yue DM, Shu LH, Li NJ and Wang JH:
Pseudolaric acid B induces caspase-dependent cell death in human
ovarian cancer cells. Oncol Rep. 31:849–857. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Morimoto H, Yonehara S and Bonavida B:
Overcoming tumor necrosis factor and drug resistance of human tumor
cell lines by combination treatment with anti-Fas antibody and
drugs or toxins. Cancer Res. 53:2591–2596. 1993.PubMed/NCBI
|
|
15
|
Brown JM: Tumor hypoxia in cancer therapy.
Methods Enzymol. 435:297–321. 2007.PubMed/NCBI
|
|
16
|
Steffen AC, Gostring L, Tolmachev V, Palm
S, Stenerlow B and Carlsson J: Differences in radiosensitivity
between three HER2 overexpressing cell lines. Eur J Nucl Med Mol
Imaging. 35:1179–1191. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akbarzadeh M, Nouri M, Banekohal MV,
Cheraghi O, Tajalli H, Movassaghpour A, Soltani S, Cheraghi H,
Feizy N, Montazersaheb S, et al: Effects of combination of
melatonin and laser irradiation on ovarian cancer cells and
endothelial lineage viability. Lasers Med Sci. 31:1565–1572. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pauwels B, Vermorken JB, Wouters A, Ides
J, Van Laere S, Lambrechts HA J, Pattyn GG, Vermeulen K, Meijnders
P and Lardon F: The role of apoptotic cell death in the
radiosensitising effect of gemcitabine. Br J Cancer. 101:628–636.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mose S, Class R, Weber HW, Rahn A, Brady
LW and Bottcher HD: Radiation enhancement by gemcitabine-mediated
cell cycle modulations. Am J Clin Oncol. 26:60–69. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Creane M, Seymour CB, Colucci S and
Mothersill C: Radiobiological effects of docetaxel (Taxotere): A
potential radiation sensitizer. Int J Radiat Biol. 75:731–737.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hermann RM, Rave-Frank M and Pradier O:
Combining radiation with oxaliplatin: A review of experimental
results. Cancer Radiother. 12:61–67. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang M, Boyer M, Rivory L, Hong A, Clarke
S, Stevens G and Fife K: Radiosensitization of vinorelbine and
gemcitabine in NCI-H460 non-small-cell lung cancer cells. Int J
Radiat Oncol Biol Phys. 58:353–360. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maurer G, Tarkowski B and Baccarini M: Raf
kinases in cancer-roles and therapeutic opportunities. Oncogene.
30:3477–3488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kurman RJ and Shih IeM: Pathogenesis of
ovarian cancer: Lessons from morphology and molecular biology and
their clinical implications. Int J Gynecol Pathol. 27:151–160.
2008.PubMed/NCBI
|
|
25
|
Yap TA, Carden CP and Kaye SB: Beyond
chemotherapy: Targeted therapies in ovarian cancer. Nat Rev Cancer.
9:167–181. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kasid U and Dritschilo A: RAF antisense
oligonucleotide as a tumor radiosensitizer. Oncogene. 22:5876–5884.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suy S, Anderson WB, Dent P, Chang E and
Kasid U: Association of Grb2 with Sos and Ras with Raf-1 upon gamma
irradiation of breast cancer cells. Oncogene. 15:53–61. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sylvain V, Lafarge S and Bignon YJ:
Molecular pathways involved in response to ionizing radiation of
ID-8 mouse ovarian cancer cells expressing exogenous full-length
Brca1 or truncated Brca1 mutant. Int J Oncol. 19:599–607.
2001.PubMed/NCBI
|
|
29
|
Kyula JN, Khan AA, Mansfield D,
Karapanagiotou EM, McLaughlin M, Roulstone V, Zaidi S, Pencavel T,
Touchefeu Y, Seth R, et al: Synergistic cytotoxicity of radiation
and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant
melanoma depends on JNK and TNF-α signaling. Oncogene.
33:1700–1712. 2014. View Article : Google Scholar : PubMed/NCBI
|
